Zhou C - Search Results

1

Diagnostic algorithm for subcentimeter hepatocellular carcinoma using alpha-fetoprotein and imaging features on gadoxetic acid-enhanced MRI.

Huang P, Wu F, Hou K, Zhou C, Xiao Y, Wang C, Miao G, Yang C, Zeng M. Huang P, et al. Among authors: zhou c. Eur Radiol. 2024 Apr;34(4):2271-2282. doi: 10.1007/s00330-023-10214-0. Epub 2023 Oct 4. Eur Radiol. 2024. PMID: 37792079

2

Combined hepatocellular carcinoma-cholangiocarcinoma: MRI features correlated with tumor biomarkers and prognosis.

Zhou C, Wang Y, Ma L, Qian X, Yang C, Zeng M. Zhou C, et al. Eur Radiol. 2022 Jan;32(1):78-88. doi: 10.1007/s00330-021-08188-y. Epub 2021 Jul 19. Eur Radiol. 2022. PMID: 34279688

3

Analysis of m6A-Related lncRNAs for Prognosis Value and Response to Immune Checkpoint Inhibitors Therapy in Hepatocellular Carcinoma.

Wang Y, Li N, Tian D, Zhou CW, Wang YH, Yang C, Zeng MS. Wang Y, et al. Among authors: zhou cw. Cancer Manag Res. 2021 Aug 16;13:6451-6471. doi: 10.2147/CMAR.S322179. eCollection 2021. Cancer Manag Res. 2021. PMID: 34429653 Free PMC article.

4

MR Features Based on LI-RADS Ver. 2018 Correlated with Cytokeratin 19 Expression in Combined Hepatocellular Carcinoma-Cholangiocarcinoma.

Zhou C, Ni X, Lu X, Wang Y, Qian X, Yang C, Zeng M. Zhou C, et al. J Hepatocell Carcinoma. 2021 Aug 21;8:975-983. doi: 10.2147/JHC.S325686. eCollection 2021. J Hepatocell Carcinoma. 2021. PMID: 34458204 Free PMC article.

5

A multidimensional nomogram combining imaging features and clinical factors to predict the invasiveness and metastasis of combined hepatocellular cholangiocarcinoma.

Wang Y, Zhou CW, Zhu GQ, Li N, Qian XL, Chong HH, Yang C, Zeng MS. Wang Y, et al. Among authors: zhou cw. Ann Transl Med. 2021 Oct;9(20):1518. doi: 10.21037/atm-21-2500. Ann Transl Med. 2021. PMID: 34790724 Free PMC article.

6

A Multi-Parametric Radiomics Nomogram for Preoperative Prediction of Microvascular Invasion Status in Intrahepatic Cholangiocarcinoma.

Qian X, Lu X, Ma X, Zhang Y, Zhou C, Wang F, Shi Y, Zeng M. Qian X, et al. Among authors: zhou c. Front Oncol. 2022 Feb 24;12:838701. doi: 10.3389/fonc.2022.838701. eCollection 2022. Front Oncol. 2022. PMID: 35280821 Free PMC article.

7

Risk stratification of LI-RADS M and LI-RADS 4/5 combined hepatocellular cholangiocarcinoma: prognostic values of MR imaging features and clinicopathological factors.

Wang Y, Zhu GQ, Zhou CW, Li N, Yang C, Zeng MS. Wang Y, et al. Among authors: zhou cw. Eur Radiol. 2022 Aug;32(8):5166-5178. doi: 10.1007/s00330-022-08691-w. Epub 2022 Mar 22. Eur Radiol. 2022. PMID: 35316365

8

Comprehensive analysis of tumor immune microenvironment and prognosis of m6A-related lncRNAs in gastric cancer.

Wang Y, Zhu GQ, Tian D, Zhou CW, Li N, Feng Y, Zeng MS. Wang Y, et al. BMC Cancer. 2022 Mar 24;22(1):316. doi: 10.1186/s12885-022-09377-8. BMC Cancer. 2022. PMID: 35331183 Free PMC article.

9

Crosstalk Between Metabolism and Immune Activity Reveals Four Subtypes With Therapeutic Implications in Clear Cell Renal Cell Carcinoma.

Wang Y, Zheng XD, Zhu GQ, Li N, Zhou CW, Yang C, Zeng MS. Wang Y, et al. Among authors: zhou cw. Front Immunol. 2022 Apr 11;13:861328. doi: 10.3389/fimmu.2022.861328. eCollection 2022. Front Immunol. 2022. PMID: 35479084 Free PMC article.

10

Diagnostic Performance of LI-RADS Version 2018 for Primary Liver Cancer in Patients With Liver Cirrhosis on Enhanced MRI.

Liu X, Ni X, Li Y, Yang C, Wang Y, Ma C, Zhou C, Lu X. Liu X, et al. Among authors: zhou c. Front Oncol. 2022 Jul 1;12:934045. doi: 10.3389/fonc.2022.934045. eCollection 2022. Front Oncol. 2022. PMID: 35847955 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21,154 results

Search Page

Filters